Penetration of cefpirome into the anterior chamber of the human eye after intravenous application

Journal of Antimicrobial Chemotherapy

Volumn 45, Issue 2, 2000, Pages 213-216

  Egger, Stefan F ^a   Alzner, Egon ^a   Georgopoulos, Michael ^b   Elmenyawi, Ibrahim ^b   Huber Spitzy, Veronika ^c   Georgopoulos, Apostolos ^b   Grabner, Günther ^a  

^a St Johanns Spital   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CEFPIROME;

ADULT; AGED; ANTERIOR EYE CHAMBER; AQUEOUS HUMOR; ARTICLE; BLOOD SAMPLING; CATARACT; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG PENETRATION; EYE INFECTION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; PARACENTESIS; PREOPERATIVE TREATMENT;

EID: 0033975078     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/45.2.213     Document Type: Article

References (15)

1. Hancock, R. F. & Bellido, F. (1996). Antibacterial in vitro activity of fourth generation cephalosporins. Journal of Chemotherapy 8, Suppl. 2, 31-6.
2. Giamarellou, H. (1996). Clinical experience with the fourth generation cephalosporins. Journal of Chemotherapy 8, Suppl. 2, 91-104.
3. Bergeron, M. G. & Bernier, M. (1994). Bactericidal acitivity of cefpirome (HR 810) against 513 Gram-negative bacteria isolated from blood of septicemic patients. Infection 22, 229-305.
4. Sader, H. S. & Jones, R. N. (1994). In vitro antimicrobial activity of cefpirome against ceftazidime-resistant isolates from two multi-center studies. European Journal of Clinical Microbiology and Infectious Diseases 13, 675-9.
5. Soussy, C. J., Chanal, M., Derlot, E., Goldstein, F. & Duval, J. (1994). In vitro antibacterial activity of cefpirome: a new cephalosporin; results of a multicenter study. Pathologie-Biologie 42, 754-60.
6. Thalhammer, F., Schmaldienst, S., Elmenyawi, I., Atteneder, M., Burgmann, H., Hollenstein, U. et al. (1996). Multiple-dose pharmaco-kinetics of cefpirome in long-term hemodialysis with high-flux membranes. Clinical Pharmacology and Therapeutics 60, 645-50.
7. Shao, J. & Tu, D. (1995). The Jackknife and the Bootstrap. Springer-Verlag, New York.
8. Hartung, J. (1993). Statistik, Lehr-und Handbuch der angewandten Statistik, 9th edn. Oldenbourg Verlag, München.
9. Barry, A. L., Brown, S. D. & Novick, W. J. (1995). In vitro activities of cefotaxime, ceftriaxone, ceftazidime, cefpirome and penicillin against Streptococcus pneumoniae isolates. Antimicrobial Agents and Chemotherapy 39, 2193-6.
10. Fitoussi, F., Doit, C., Sandin, A., Pechinot, A., Kazmierczack, A., Geslin, P. et al. (1995). Killing activity of cefpirome against penicillin-resistant Streptococcus pneumoniae isolates from patients with meningitis in a pharmacodynamic model simulating the cerebrospinal fluid concentration profile. Antimicrobial Agents and Chemotherapy 39, 2560-3.
11. Bajaksouzian, S., Visalli, M. A., Jacobs, M. R. & Appelbaum, P. C. (1996). Antipneumococcal activities of cefpirome and cefotaxime, alone and in combination with vancomycin and teicoplanin, determined by checkerboard and time-kill methods. Antimicrobial Agents and Chemotherapy 40, 1973-6.
12. Baltch, A. L., Smith, R. P. & Ritz, W. (1994). Comparative antimicrobial acitvity of FK037, cefpirome, ceftazidime and cefepime against aminoglycoside-sensitive and aminoglycoside-resistant Pseudomonas aeruginosa and Pseudomonas spp. Chemotherapy 40, 391-8.
13. Fantin, B., Farinotti, R., Thabaut, A. & Carbon, C. (1994). Conditions for the emergence of resistance to cefpirome and ceftazidime in experimental endocarditis due to Pseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy 33, 563-9.
14. Quentin, C. D. & Ansorg, R. (1983). Penetration of cefotaxime into the aqueous humour of the human eye after intravenous application. Graefes Archive for Clinical and Experimental Ophthalmology 220, 245-7.
15. Kanski, J. J., Young, J. H. & Vogel, R. (1982). Penetration of intravenously administered cefoxitin into the aqueous humor of inflamed human eyes. American Journal of Ophthalmology 94, 516-8.